Aquestive Therapeutics, Inc.AQSTNASDAQ
LOADING
|||
Price to Sales: Premium Valuation
Trending higher, above historical average, slight contraction.
Left:
||||
Price-to-sales ratio
Latest
5.36
↑ 48% above average
Average (8y)
3.63
Historical baseline
Range
High:7.59
Low:0.92
CAGR
-4.3%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 5.36 | +119.3% |
| 2023 | 2.45 | +165.3% |
| 2022 | 0.92 | -68.4% |
| 2021 | 2.91 | -25.8% |
| 2020 | 3.93 | +40.0% |
| 2019 | 2.81 | +44.9% |
| 2018 | 1.94 | -59.6% |
| 2017 | 4.80 | -36.8% |
| 2016 | 7.59 | - |